272 related articles for article (PubMed ID: 19197995)
1. Interstitial wires releasing diffusing alpha emitters combined with chemotherapy improved local tumor control and survival in squamous cell carcinoma-bearing mice.
Cooks T; Arazi L; Efrati M; Schmidt M; Marshak G; Kelson I; Keisari Y
Cancer; 2009 Apr; 115(8):1791-801. PubMed ID: 19197995
[TBL] [Abstract][Full Text] [Related]
2. Local control of lung derived tumors by diffusing alpha-emitting atoms released from intratumoral wires loaded with radium-224.
Cooks T; Schmidt M; Bittan H; Lazarov E; Arazi L; Kelson I; Keisari Y
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):966-73. PubMed ID: 19480976
[TBL] [Abstract][Full Text] [Related]
3. Growth retardation and destruction of experimental squamous cell carcinoma by interstitial radioactive wires releasing diffusing alpha-emitting atoms.
Cooks T; Arazi L; Schmidt M; Marshak G; Kelson I; Keisari Y
Int J Cancer; 2008 Apr; 122(7):1657-64. PubMed ID: 18059026
[TBL] [Abstract][Full Text] [Related]
4. Treatment of solid tumors by interstitial release of recoiling short-lived alpha emitters.
Arazi L; Cooks T; Schmidt M; Keisari Y; Kelson I
Phys Med Biol; 2007 Aug; 52(16):5025-42. PubMed ID: 17671351
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral 224Ra-loaded wires spread alpha-emitters inside solid human tumors in athymic mice achieving tumor control.
Cooks T; Tal M; Raab S; Efrati M; Reitkopf S; Lazarov E; Etzyoni R; Schmidt M; Arazi L; Kelson I; Keisari Y
Anticancer Res; 2012 Dec; 32(12):5315-21. PubMed ID: 23225432
[TBL] [Abstract][Full Text] [Related]
6. Ablation of experimental colon cancer by intratumoral 224Radium-loaded wires is mediated by alpha particles released from atoms which spread in the tumor and can be augmented by chemotherapy.
Reitkopf-Brodutch S; Confino H; Schmidt M; Cooks T; Efrati M; Arazi L; Rath-Wolfson L; Marshak G; Kelson I; Keisari Y
Int J Radiat Biol; 2015 Feb; 91(2):179-86. PubMed ID: 25179346
[TBL] [Abstract][Full Text] [Related]
7. The treatment of solid tumors by alpha emitters released from (224)Ra-loaded sources-internal dosimetry analysis.
Arazi L; Cooks T; Schmidt M; Keisari Y; Kelson I
Phys Med Biol; 2010 Feb; 55(4):1203-18. PubMed ID: 20124656
[TBL] [Abstract][Full Text] [Related]
8. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
Vink SR; Lagerwerf S; Mesman E; Schellens JH; Begg AC; van Blitterswijk WJ; Verheij M
Clin Cancer Res; 2006 Mar; 12(5):1615-22. PubMed ID: 16533789
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of cisplatin and 5-fluorouracil with irradiation on tumor cells in vitro.
Nagy B; Mucsi I; Molnár J; Thurzo L
Anticancer Res; 2002; 22(1A):135-8. PubMed ID: 12017276
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin.
Goto H; Yano S; Matsumori Y; Ogawa H; Blakey DC; Sone S
Clin Cancer Res; 2004 Nov; 10(22):7671-6. PubMed ID: 15570000
[TBL] [Abstract][Full Text] [Related]
12. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Donnelly ET; Kelley M; Rockwell S
Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
[TBL] [Abstract][Full Text] [Related]
13. Combined VSV oncolytic virus and chemotherapy for squamous cell carcinoma.
Sung CK; Choi B; Wanna G; Genden EM; Woo SL; Shin EJ
Laryngoscope; 2008 Feb; 118(2):237-42. PubMed ID: 18043494
[TBL] [Abstract][Full Text] [Related]
14. Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.
Henriksen G; Breistøl K; Bruland ØS; Fodstad Ø; Larsen RH
Cancer Res; 2002 Jun; 62(11):3120-5. PubMed ID: 12036923
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.
Ghosh S; Maity P
Int Immunopharmacol; 2006 Oct; 6(10):1550-9. PubMed ID: 16919827
[TBL] [Abstract][Full Text] [Related]
17. E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma.
Adhim Z; Lin X; Huang W; Morishita N; Nakamura T; Yasui H; Otsuki N; Shigemura K; Fujisawa M; Nibu K; Shirakawa T
Cancer Gene Ther; 2012 Feb; 19(2):144-52. PubMed ID: 22116375
[TBL] [Abstract][Full Text] [Related]
18. [Experimental studies on anti-tumor effects of BLC-modified tumor cell vaccine combined with cisplatin].
Zou CH; Tian L; Wei YQ; Zhao X; Kan B; Yang JL; Mao YQ; Wen YJ; Li J; Deng HX
Ai Zheng; 2004 Jan; 23(1):1-7. PubMed ID: 14720366
[TBL] [Abstract][Full Text] [Related]
19. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
20. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
